Treating Nicotine Dependence in Schizophrenic Individuals: Effectiveness of Bupropion - 1
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
Schizophrenic individuals are typically nicotine dependent smokers who find it difficult to
quit smoking. The purpose of this study is to determine the effectiveness of bupropion SR
(commonly known as Zyban) in combination with a nicotine transdermal patch (NTP), in helping
schizophrenic individuals quit smoking. In addition, this study will evaluate how the
combination of bupropion SR and NTP affects psychiatric symptoms and medication side effects.